Welcome to our dedicated page for Imac Hldgs SEC filings (Ticker: BACK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Struggling to decode how a regenerative-medicine clinic operator accounts for proteomic testing costs or clinic build-outs? IMAC Holdings Inc’s SEC disclosures weave medical regulations, insurance reimbursement rules, and clinic economics into 200-page reports—details every healthcare investor needs yet few have time to mine.
Stock Titan’s AI-powered summaries turn dense language into plain English. Open an IMAC Holdings Inc annual report 10-K simplified to see capital-expenditure trends, or skim an IMAC Holdings Inc quarterly earnings report 10-Q filing for same-clinic revenue shifts in seconds. Our engine flags each IMAC Holdings Inc 8-K material events explained and delivers IMAC Holdings Inc Form 4 insider transactions real-time so you know when executives buy shares before announcing new BackSpace locations.
Every filing type appears the moment it hits EDGAR—10-K, 10-Q, 8-K, S-1, DEF 14A, plus IMAC Holdings Inc proxy statement executive compensation. Click once to surface:
- Segment profitability of IMAC Regeneration Centers vs. BackSpace clinics
- Regulatory language on FDA oversight of regenerative procedures
- Reimbursement assumptions that affect gross margins
- IMAC Holdings Inc insider trading Form 4 transactions with instant alerts
Need deeper context? Our experts add concise notes—find “understanding IMAC Holdings Inc SEC documents with AI” beside each section, plus ratio analysis that links patient-visit counts to revenue recognition. Whether you’re tracking an IMAC Holdings Inc earnings report filing analysis before the call or monitoring IMAC Holdings Inc executive stock transactions Form 4, you’ll spend minutes, not hours, pulling insights that shape investment decisions.
No more sifting through footnotes—explore IMAC Holdings Inc SEC filings explained simply, updated in real time, and make informed moves with confidence.
IMAC Holdings, Inc. (ticker: BACK) filed an 8-K on 17 Jun 2025 disclosing a new promissory note. The company issued an unsecured note with an aggregate principal of $301,000 in exchange for $215,000 cash proceeds from a single lender, implying a substantial original-issue discount. The note carries a short maturity date of 24 Dec 2025—about six months—suggesting near-term repayment pressure. Management can prepay at any time without penalty, which provides financial flexibility. Standard representations, covenants and bankruptcy-related default triggers apply; upon default, the lender may accelerate repayment. No collateral, equity conversion features, or warrants were disclosed, and the instrument references the form of note previously filed on 6 May 2025 (Exhibit 4.1).
Key implications for investors:
- The additional borrowing modestly increases leverage for this micro-cap company, though the absolute dollar amount is small.
- The unsecured structure avoids encumbering assets, but the discount (≈29% between principal and cash received) indicates a high effective cost of capital.
- Management’s ability to prepay without penalty could reduce interest expense if cash flow permits early retirement.
- The short tenor concentrates refinancing/repayment risk into the next two quarters, making future liquidity updates important.
No other material agreements, financial statements, or earnings data accompanied the filing.
FAQ
What is the current stock price of Imac Hldgs (BACK)?
What is the market cap of Imac Hldgs (BACK)?
